Dr. Cecelia Calhoun ’21, a Yale physician with a focus on sickle cell disease, and Yale SOM’s Dr. Howard Forman discuss the gargantuan but critical challenge of addressing the impact of systemic racism on the health of Black Americans.
Nationally, infection rates are close to their low point and many Americans are resuming their usual activities, but the more transmissible Delta variant is spreading and vaccinations are still low in some areas. We asked Yale SOM's Dr. Howard Forman where things stand now.
The healthcare industry produces 8.5% of all U.S. greenhouse gas emissions as well as other forms of air pollution. Yale's Dr. Jodi Sherman says the first step to making healthcare sustainable is to understand the scope of the problem.
A Yale study conducted in the early days of the COVID-19 pandemic found that feeling like part of a team reduced reported stress and burnout—an insight with implications for how any kind of organization can weather a crisis.
Using data from infrared location tracking tags, Yale SOM’s Lesley Meng and her co-authors determined that nurses visit rooms that are farther from the nurses station less frequently, but for longer.
Professor Teresa Chahine talks with Roderick Bremby, who led a dramatic turnaround of Connecticut's Supplemental Nutrition Assistance Program. Today, he is an executive at Salesforce, which has provided contact tracing and vaccine management during the COVID-19 pandemic.
In a new paper, Yale SOM’s Paul Goldsmith-Pinkham and his co-authors find that when Americans turn 65 and start to receive health insurance through Medicare, there is a measurable decline in debt, particularly in the South and among those with the greatest debt.
A new Yale study says that a partnership with the Dollar General retail chain, which is being considered by the CDC, could bring vaccination sites substantially closer to low-income, Black, and Hispanic households in many parts of the United States.
What will change the minds of those reluctant to get the COVID-19 vaccine? Yale SOM’s Vineet Kumar and two Yale doctors used the tools of consumer marketing to survey hesitant healthcare workers and analyze their responses.
Josh Geballe ’02, Connecticut’s chief operating officer, explains the state’s controversial decision to switch to age-based eligibility for COVID vaccines—and says it likely saved lives.
There is another epidemic we cannot lose sight of: the opioid epidemic, which has become only more acute in the United States and elsewhere amidst the disruptions and stress caused by COVID-19.